Your browser doesn't support javascript.
loading
Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting.
Miyahira, Andrea K; Roychowdhury, Sameek; Goswami, Sangeeta; Ippolito, Joseph E; Priceman, Saul J; Pritchard, Colin C; Sfanos, Karen S; Subudhi, Sumit K; Simons, Jonathan W; Pienta, Kenneth J; Soule, Howard R.
  • Miyahira AK; Prostate Cancer Foundation, Santa Monica, California.
  • Roychowdhury S; Comprehensive Cancer Center, Department of Internal Medicine, Ohio State University, Columbus, Ohio.
  • Goswami S; Division of Medical Oncology, Ohio State University, Cincinnati, Ohio.
  • Ippolito JE; Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Priceman SJ; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Pritchard CC; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri.
  • Sfanos KS; Departments of Hematology and Hematopoietic Cell Transplantation, and Immuno-Oncology, Beckman Research Institute at City of Hope National Medical Center, Duarte, California.
  • Subudhi SK; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
  • Simons JW; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Pienta KJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Soule HR; Department of Urology, The James Buchanan Brady Urological Institute, Baltimore, Maryland.
Prostate ; 77(2): 123-144, 2017 02.
Article en En | MEDLINE | ID: mdl-27679977
ABSTRACT

INTRODUCTION:

The 2016 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Beyond Seed and Soil Understanding and Targeting Metastatic Prostate Cancer," was held from June 23 to June 26, 2016, in Coronado, California.

METHODS:

For the 4th year in a row, the Prostate Cancer Foundation (PCF) hosted the CHPCA Meeting, a think tank-structured scientific conference, which focuses on a specific topic of critical unmet need on the biology and treatment of advanced prostate cancer. The 2016 CHPCA Meeting was attended by 71 investigators from prostate cancer and other fields, who discussed the biology, study methodologies, treatment strategies, and critical unmet needs concerning metastatic prostate cancer, with the ultimate goal of advancing strategies to treat and eliminate this disease.

RESULTS:

The major topics of discussion included the molecular landscape and molecular heterogeneity of metastatic prostate cancer, the role of the metastatic microenvironment, optimizing immunotherapy in metastatic prostate cancer, learning from exceptional responders and non-responders, targeting DNA repair deficiency in advanced prostate cancer, developing and applying novel biomarkers and imaging techniques, and potential roles for the microbiome in prostate cancer.

DISCUSSION:

This article reviews the topics presented and discussions held at the CHPCA Meeting, with a focus on the unknowns and next steps needed to advance our understanding of the biology and most effective treatment strategies for metastatic prostate cancer. Prostate 77123-144, 2017. © 2016 Wiley Periodicals, Inc.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Congresos como Asunto / Academias e Institutos / Informe de Investigación / Inmunoterapia / Antineoplásicos Tipo de estudio: Qualitative_research Límite: Animals / Humans / Male País como asunto: America do norte Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Congresos como Asunto / Academias e Institutos / Informe de Investigación / Inmunoterapia / Antineoplásicos Tipo de estudio: Qualitative_research Límite: Animals / Humans / Male País como asunto: America do norte Idioma: En Año: 2017 Tipo del documento: Article